Appgest 40 Tablet
Marketer
Merynova Lifesciences India Private Limited
Salt Composition
Megestrol (40mg)
Overview Appgest 40 Tablet
Megestrol 40mg tablets are indicated for the management of breast and uterine cancers exhibiting hormone dependence. This medication also offers potential benefits in addressing anorexia and unintentional weight loss associated with advanced cancers or HIV infection. Dosage and duration of treatment should be determined solely by your physician. The medication may be administered with or without food, though consistent timing is recommended. Continue taking this medication for the prescribed period. Commonly reported adverse effects encompass weight increase, enhanced appetite, dyspnea, vasomotor flushes (facial and neck warmth), hypertension, and constipation. These reactions are often transient, resolving as the body adapts to therapy. Report any persistent or bothersome side effects to your doctor; options for mitigation may be available. Full disclosure of all current medications is crucial, as interactions may impact efficacy or alter the medication's mechanism of action. This medication is contraindicated during pregnancy and lactation. Routine blood tests to monitor hormone and glucose levels are typically conducted during treatment.
Primary Ingredients of Appgest 40 Tablet
No information provided. Please provide the text you wish me to rephrase.
Uses of Appgest 40 Tablet
Cancers of the breast and uterine lining
Major Benefits of Appgest 40 Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Appgest 40 Tablets can be administered with or without food, though consistent timing is recommended.
Common Side effects of Appgest 40 Tablet:
- Increased appetite
- Weight gain
- Hot flashes
- High blood pressure
- Constipation
How to use Appgest 40 Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for Appgest 40 Tablet. Always swallow the tablet whole; avoid chewing, crushing, or breaking it. While Appgest 40 Tablet can be administered with or without food, consistent timing is recommended.
How Appgest 40 Tablet works:
Appgest 40 tablets contain a progestin, a type of female hormone. In individuals with breast or endometrial cancer, this medication modifies the hormones contributing to tumor development. A side effect is increased appetite, leading to weight gain.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Appgest 40 Tablet may be unsafe; physician consultation is recommended.
PregnancyUNSAFE
Using Appgest 40 Tablet during pregnancy carries substantial risks. Pregnant women should consult their physician; research in animal and human studies reveals considerable harm to the fetus.
Breast feedingCONSULT YOUR DOCTOR
The use of Appgest 40 Tablet while breastfeeding is likely inadvisable. Scant human evidence indicates potential drug transfer to breast milk, posing a possible risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by Appgest 40 Tablet.
KidneyCAUTION
Patients with significant kidney impairment should exercise caution when using Appgest 40 Tablets. Dosage modification may be necessary. Physician consultation is advised.
LiverCAUTION
For individuals with severe hepatic impairment, Appgest 40 Tablet requires careful administration. Dosage modification of Appgest 40 Tablet may be necessary. Physician consultation is advised.
What if you forget to take Appgest 40 Tablet :
NA
Facts to Know About Appgest 40 Tablet
| Label | Value |
|---|---|
| Chemical Category | Synthetic Progestins |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |



